Ellevest, Inc. Aeglea Bio Therapeutics, Inc. Transaction History

Ellevest, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$6.03 - $7.95 $904 - $1,192	-150 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$6.32 - $8.38 $233 - $310	37 Added 32.74%	150 $1,000
Q1 2021 May 03, 2021	BUY	$6.76 - $8.57 $216 - $274	32 Added 39.51%	113 $1,000
Q3 2020 Oct 26, 2020	BUY	$6.51 - $9.33 $527 - $755	81 New	81 $1,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.